Printer Friendly
The Free Library
14,715,713 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

PHARMAGENESIS APPROVED TO SELL FERIDEX IN CHINA.


Pharmagenesis Inc. has received approval from the Chinese State Drug Administration (SDA SDA
abbr.
specific dynamic action


Serotonin dopamine antagonist (SDA)
The newer second-generation antipsychotic drugs, also called atypical antipsychotics.
) to market and sell Feridex, an organ-specific magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures.  contrast agent that allows for the early detection of liver lesions, in China.

Approximately 240 million people in China are carriers of the hepatitis B Hepatitis B Definition

Hepatitis B is a potentially serious form of liver inflammation due to infection by the hepatitis B virus (HBV). It occurs in both rapidly developing (acute) and long-lasting (chronic) forms, and is one of the most common chronic
 virus, which is a leading cause of hepatoma hepatoma /hep·a·to·ma/ (hep?ah-to´mah)
1. a tumor of the liver.

2. hepatocellular carcinoma (malignant h.).


hep·a·to·ma
n. pl.
, one of the top 10 cancers in China. Ten percent of carriers are likely to develop the disease.

Pharmagenesis has begun providing the drug, developed by Advanced Magnetics Inc. (AMI), to Chinese government-sponsored oncology and teaching hospitals, including the renowned Beijing Tumor Hospital, the Shanghai Tumor Hospital and the Peking Union Medical College Peking Union Medical College, Tsinghua University (北京协和医学院,清华大学医学部) [1] is among the most selective medical colleges in the People's Republic of China and is renowned  Hospital, one of the major teaching institutions in China. Feridex allows for the diagnosis and prognosis of liver diseases including hepatoma.

"We are encouraged by the wide acceptance of Feridex by oncology doctors in China," Nicolas Druz, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  and chairman of the board, Pharmagenesis, said. "The launch of Feridex is an excellent preparation for our plans to import more oncology-related Western drugs to China."

Pharmagenesis received an exclusive license from AMI for the distribution of Feridex to China and Taiwan in 1996.

About Advanced Magnetics Inc.

Advanced Magnetics Inc. is a medical specialty company dedicated to the development and commercialization of pharmaceutical products for the diagnosis of cancer and other diseases. For more information, visit the company's web site at www.advancedmagnetics.com.

About Pharmagenesis Inc.

Pharmagenesis Inc. develops anticancer therapies and treatments for cancer therapy-related bone-marrow suppression and for the management of transplant rejection. The privately held company privately held company

A firm whose shares are held within a relatively small circle of owners and are not traded publicly.
 focuses on developing ethical pharmaceuticals from purified extracts of plants that have been employed in traditional Chinese medicine Traditional Chinese Medicine Definition

Traditional Chinese medicine (TCM) is an ancient and still very vital holistic system of health and healing, based on the notion of harmony and balance, and employing the ideas of moderation and prevention.
 for more than 4,000 years. Efficacy is validated by clinical trials conforming to standards of appropriate government regulatory agencies. Pharmaceuticals developed and/or licensed by the company are being commercialized initially in the high-growth markets of China and Taiwan.

Pharmagenesis has its corporate headquarters and R & D facility, employing cutting-edge Western medical research techniques, in Palo Alto, Calif. Pharmagenesis also has operations in Beijing and Taipei.

For more information, call (310)785-0515, ext. 264/270.
COPYRIGHT 2001 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:PHARMAGENESIS APPROVED TO SELL FERIDEX IN CHINA.
Publication:Worldwide Biotech
Geographic Code:1USA
Date:Apr 1, 2001
Words:351
Previous Article:NEWBIOTICS/ELAN TO DEVELOP COLON CANCER TREATMENT.
Next Article:FAULDING ACQUIRES RIGHTS TO PACLITAXEL IN EUROPE.
Topics:



Related Articles
PHARMAGENESIS INC. RECEIVES FUNDING FROM NEW INVESTORS.
Taiwan: EgrAegis.(negative effects produced by arms sale to Taiwan)(Brief Article)
PHARMAGENESIS JOINT VENTURE TO MAKE/SELL PG2 IN CHINA.
CHINA CERTIFIES PHARMAGENESIS' BONE MARROW STIMULANT PG2.
China Reaches WTO Deal.(World Trade Organization)
BUSINESS NOTES AREA HOME PRICES REACH NEW PEAK.(Business)
HAIR PRODUCTS MAKER SUES PARTNER FOR FRAUD.(News)
MILLER ON PROCUREMENT.
PIERRE FABRE LICENSES PHARMAGENESIS ANTI-CANCER HERBAL DRUG.
China adopts fuel-efficiency standards.(ENVIRONMENTAL Intelligence)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles